期刊文献+

3.0T磁共振弹性成像评价非酒精性脂肪肝及预测脂性肝炎 被引量:9

Evaluation of non-alcoholic fatty liver disease and prediction of liver fibrosis by 3.0T magnetic resonance elastography
下载PDF
导出
摘要 目的:探讨3.0T MR弹性成像(MRE)评价非酒精性脂肪肝(Non-alcoholic fatty liver disease,NAFLD)患者肝纤维化的作用。方法:采用3.0T MRE分析20例健康志愿者(正常组)及57例肝脏活检诊断患有NAFLD的患者(病变组)的肝脏弹性值。采用受试者工作特征曲线(ROC)评价MRE鉴别NAFLD的诊断效能。结果:正常组及病变组的肝脏弹性值分别为(1.97±0.43)kPa及(4.05±1.70)kPa,二者间差异有统计学意义(t=-8.518,P<0.001);MRE诊断NAFLD≥F1、≥F2、≥F3及F4的ROC曲线下面积(AUC)均高于NAFLD纤维化分数(NFS),分别为0.92(NFS:0.74)、0.94(NFS:0.81)、0.95(NFS:0.85)、0.99(NFS:0.91)(AUC值比较P均<0.05)。结论:MRE是一种可靠的评价NAFLD患者纤维化分期的方法,优于血清学指标。 Objective: To investigate the effect of 3.0 T magnetic resonance elastography(MRE) on the evaluation of non-alcoholic fatty liver disease(NAFLD) patients and prediction the liver fibrosis. Methods: The preoperative liver stiffness of 20 healthy volunteers(normal group) and 57 patients(pathological group) diagnosed with NAFLD by liver biopsy were analyzed by 3.0 T MRE. Receiver operating characteristic curve(ROC) was used to evaluate the diagnostic efficacy of MRE in the staging liver fibrosis. Results: The shear stiffness of the normal group and the pathological group were(1.97±0.43) kPa and(4.05±1.70) kPa,with statistical significance(t=-8.518, P<0.001). The AUC of MRE for diagnosising ≥F1, ≥F2, ≥F3 and F4 liver fibrosis in NAFLD patients was 0.92, 0.94, 0.95 and 0.99, respectively, all of which were higher than that of NFS(0.74, 0.81, 0.85 and 0.91, respectively). Conclusion: MRE is a reliable tool for the evaluation of different stages of fibrosis in NAFLD patients.
作者 张显怡 纪若云 蔡小丽 石喻 ZHANG Xian-yi;JI Ruo-yun;CAI Xiao-li;SHI Yu(Department of Radiology,Shengjing Hospital of China Medical University,Shenyang 110004,China)
出处 《中国临床医学影像杂志》 CAS 2019年第12期859-862,共4页 Journal of China Clinic Medical Imaging
基金 国家自然科学基金面上项目(81771802,81771893)
关键词 脂肪肝 肝炎 磁共振成像 Fatty liver Hepatitis Magnetic resonance imaging
  • 相关文献

参考文献2

二级参考文献25

  • 1Yan-Yan Ma,Lin Li,Chao-Hui Yu,Zhe Shen,Li-Hua Chen,You-Ming Li.Effects of probiotics on nonalcoholic fatty liver disease:A meta-analysis[J].World Journal of Gastroenterology,2013,19(40):6911-6918. 被引量:33
  • 2Adnan Said.Non-alcoholic fatty liver disease and liver transplantation:Outcomes and advances[J].World Journal of Gastroenterology,2013,19(48):9146-9155. 被引量:16
  • 3Sunder Mudaliar,Robert R. Henry,Arun J. Sanyal,Linda Morrow,Hanns-Ulrich Marschall,Mark Kipnes,Luciano Adorini,Cathi I. Sciacca,Paul Clopton,Erin Castelloe,Paul Dillon,Mark Pruzanski,David Shapiro.Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease[J].Gastroenterology.2013
  • 4Shaohua Chen,Narci C Teoh,Shiv Chitturi,Geoffrey C Farrell.Coffee and non‐alcoholic fatty liver disease: Brewing evidence for hepatoprotection?[J].J Gastroenterol Hepatol.2014(3)
  • 5Martin Rossmeisl,Dasa Medrikova,Evert M. van Schothorst,Jana Pavlisova,Ondrej Kuda,Michal Hensler,Kristina Bardova,Pavel Flachs,Barbora Stankova,Marek Vecka,Eva Tvrzicka,Ales Zak,Jaap Keijer,Jan Kopecky.Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice[J].BBA - Molecular and Cell Biology of Lipids.2014(2)
  • 6R. Kwok,Y.‐K. Tse,G. L.‐H. Wong,Y. Ha,A. U. Lee,M. C. Ngu,H. L.‐Y. Chan,V. W.‐S. Wong.Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments[J].Aliment Pharmacol Ther.2014(3)
  • 7Hellan K. Kwon,Joel K. Greenson,Hari S. Conjeevaram.Effect of lifetime alcohol consumption on the histological severity of non‐alcoholic fatty liver disease[J].Liver Int.2014(1)
  • 8Jean P. Molleston,Jeffrey B. Schwimmer,Katherine P. Yates,Karen F. Murray,Oscar W. Cummings,Joel E. Lavine,Elizabeth M. Brunt,Ann O. Scheimann,Aynur Unalp-Arida.Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels[J].The Journal of Pediatrics.2013
  • 9J. H. Hoofnagle,M. L. Natta,D. E. Kleiner,J. M. Clark,K. V. Kowdley,R. Loomba,B. A. Neuschwander‐Tetri,A. J. Sanyal,J. Tonascia.Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis[J].Aliment Pharmacol Ther.2013(2)
  • 10Jun Wang,Xufeng Guo,Pengbo Wu,Jia Song,Chuncui Ye,Shijie Yu,Jixiang Zhang,Weiguo Dong.Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: A meta-analysis[J].Gene.2013

共引文献47

同被引文献95

引证文献9

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部